PlainRecalls
FDA Drug Moderate Class II Terminated

Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc., Indianapolis, IN 46268; Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 57665-101-41

Reported: February 22, 2023 Initiated: February 3, 2023 #D-0327-2023

Product Description

Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc., Indianapolis, IN 46268; Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 57665-101-41

Reason for Recall

Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.

Details

Units Affected
31,879 vials
Distribution
Nationwide USA
Location
Gaithersburg, MD

Frequently Asked Questions

What product was recalled?
Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exelead, Inc., Indianapolis, IN 46268; Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 57665-101-41. Recalled by Leadiant Biosciences, Inc.. Units affected: 31,879 vials.
Why was this product recalled?
Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 22, 2023. Severity: Moderate. Recall number: D-0327-2023.